AVALON BIOVENTURES MANAGEMENT, LLC
AVALON BIOVENTURES MANAGEMENT, LLC is a Pre-seed, Seed and Series A fund in the US investing in Healthcare and biotechnology.
- Stages
- Pre-seed, Seed, Series A
- Sectors
- Healthcare, biotechnology
- Invests in
- US-wide
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 1983
- Assets under management
- $750M
- Website
- avalonbioventures.com
Check size not disclosed
Thesis
Avalon BioVentures is a venture capital firm with over 40 years of experience, specializing in early-stage biomedical innovation within the life sciences sector. Their investment thesis focuses on identifying and nurturing 'first-in-class' innovations that address significant unmet medical needs, often investing in opportunities considered too early by others. They employ a hands-on strategy, including company formation and incubation through their ABV Accelerator, which provides scientific, operational, and financial resources. Avalon typically leads investment rounds, focusing on pre-seed, seed, and Series A stages, primarily in North America, with a strong presence in the US, particularly the San Diego biotech hub. Their first venture fund, ABV1, closed in December 2022 with $135 million, and historically they have managed approximately $750 million across 11 funds, investing in over 50 biotech and health tech companies.
Common questions
Does AVALON BIOVENTURES MANAGEMENT, LLC invest at the Pre-seed stage?
Yes. AVALON BIOVENTURES MANAGEMENT, LLC lists Pre-seed, Seed and Series A among the stages it invests in.
Where does AVALON BIOVENTURES MANAGEMENT, LLC invest?
AVALON BIOVENTURES MANAGEMENT, LLC invests in the US.